Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1981 1
1982 2
1983 1
1986 1
1988 1
1991 1
1992 2
1993 2
1998 1
2002 1
2007 1
2015 3
2016 3
2017 1
2020 1
2021 5
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, Rakovitch E, Chang L, Stevens C, Bowen J, Provencher S, Théberge V, Mulligan AM, Kos Z, Akra MA, Voduc KD, Hijal T, Dayes IS, Pond G, Wright JR, Nielsen TO, Levine MN; LUMINA Study Investigators. Whelan TJ, et al. N Engl J Med. 2023 Aug 17;389(7):612-619. doi: 10.1056/NEJMoa2302344. N Engl J Med. 2023. PMID: 37585627
Regional Nodal Irradiation in Early-Stage Breast Cancer.
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN; MA.20 Study Investigators. Whelan TJ, et al. N Engl J Med. 2015 Jul 23;373(4):307-16. doi: 10.1056/NEJMoa1415340. N Engl J Med. 2015. PMID: 26200977 Free PMC article. Clinical Trial.
Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
Carpenter J, Forero A, Falkson CI, Nabell LM, De Los Santos JF, Krontiras H, Bland KI, Li Y, Bae S. Carpenter J, et al. South Med J. 2020 Nov;113(11):559-563. doi: 10.14423/SMJ.0000000000001169. South Med J. 2020. PMID: 33140109 Free PMC article.
Suramin in combination with mitomycin C in hormone-resistant prostate cancer. A phase II clinical study.
Rapoport BL, Falkson G, Raats JI, de Wet M, Lotz BP, Potgieter HC. Rapoport BL, et al. Ann Oncol. 1993 Aug;4(7):567-73. doi: 10.1093/oxfordjournals.annonc.a058590. Ann Oncol. 1993. PMID: 8363988 Free article. Clinical Trial.
BACKGROUND: Hormone-resistant prostate cancer can respond to mitomycin C or to suramin. This trial was undertaken to investigate the value of mitomycin C given with low dose suramin. ...The median time to treatment failure was 103 days, and the median survival 209 d …
BACKGROUND: Hormone-resistant prostate cancer can respond to mitomycin C or to suramin. This trial was undertaken to investigate the …
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer.
Falkson CI, Falkson G, Falkson CB, Falkson HC. Falkson CI, et al. Oncology. 1992;49(6):418-21. doi: 10.1159/000227084. Oncology. 1992. PMID: 1465278 Clinical Trial.
A pilot study was undertaken to compare mitomycin C plus oral high-dose medroxyprogesterone acetate (MMPA) to cyclophosphamide+doxorubicin+ fluorouracil (CAF). ...Although there were more objective responses on CAF, this was not statistically significantly different, and C …
A pilot study was undertaken to compare mitomycin C plus oral high-dose medroxyprogesterone acetate (MMPA) to cyclophosphamide+doxoru …
Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
Falkson G, Pretorius HL, Falkson HC, Schoeman HS. Falkson G, et al. Cancer Chemother Pharmacol. 1983;11(3):203-4. doi: 10.1007/BF00254206. Cancer Chemother Pharmacol. 1983. PMID: 6416696
Thirty patients with advanced measurable colorectal cancer received monthly courses of a combination of dacarbazine, mitomycin C, 5-fluorouracil, and vincristine (FIVMit-Or). Four of the patients had received prior chemotherapy. ...
Thirty patients with advanced measurable colorectal cancer received monthly courses of a combination of dacarbazine, mitomycin C, 5-f …
30 results